您当前的位置:
6-gingerol (Synonyms: [6]-姜辣素; (S)-(+)-[6]Gingerol)
目录号: PC13324 纯度: ≥98%
CAS No. :23513-14-6
商品编号 规格 价格 会员价 是否有货 数量
PC13324-20mg 20mg ¥141.25 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
6-gingerol
中文别名
6-姜酚;(5S)-5-羟基-1-(4-羟基-3-甲氧基苯基)癸-3-酮;没食子酚儿茶素;姜辣素;6-姜辣醇;姜酮醇;[6]-姜辣素;[6]-姜酚;13-去羟基印乌碱;6-姜醇(P);6-姜酚 标准品;6-姜酚(标准品);6-姜酚, 来源于生姜;6-姜酚 植物提取物,标准品,对照品;6-姜辣素;黑胡椒精油;姜;生姜精油;(S)-5-羟基-1-(4-羟基-3-甲氧苯基)-3-癸酮;6-姜酚:6-姜辣素;6-姜辣素对照品标准品;6-姜酮醇;5-羟基-1-(4-羟基-3-甲氧基苯基)-3-癸酮;6-姜酚;6-姜辣素;6-姜酚,6-姜辣素
英文名称
6-gingerol
英文别名
(S)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one;1-(4'-HYDROXY-3'-METHOXYPHENYL)-5-HYDROXY-3-DECANONE;5-HYDROXY-1-(4'-HYDROXY-3'-METHOXYPHENYL)-3-DECANONE;(5s)-5-hydroxy-1-(4-hydroxy-3-methoxy-phenyl)decan-3-one;[6]-GINGEROL, ZINGIBER OFFICINALE;GINGEROL;GINGEROL [6];(S)-5-HYDROXY-1-(4-HYDROXY-3-METHOXY-PHENYL-3-DECANONE;(s)-( )-(6)gingerol;(s)-( )-3-decanon;(s)-(6)-gingerol;(s)-3-decanon;Gingerols;6-Gingerol std.;3-Decanone, 5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-, (S);rac-(R*)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)decane-3-one;(5S)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-decanone;(S)-8-Oxo-10-(3-methoxy-4-hydroxyphenyl)decane-6-ol;(+)-[6]-Gingerol;[6]-Gingerol;6-gingerol;GINGEROL, 6-(P) PrintBack;(5S)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one;(S)-(+)-[6]Gingerol;(S)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-decanone;3-Decanone (5-hydroxy-1-(4-hydroxy-3-methoxyphenyl);Ginger Extract;(6)-Gingerol;3-Decanone, 5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-, (5S)-;(+)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-decanone;5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-decanone;92
Cas No.
23513-14-6
分子式
C17H26O4
分子量
294.39
包装储存
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
生物活性

[6]-Gingerol is an active compound isolated from Ginger (Zingiber officinale), exhibits a variety of biological activities including anticancer, anti-inflammation, and anti-oxidation.

性状

Solid

IC50 & Target[1][2]

AMPK

 

Apoptosis

 

体外研究(In Vitro)

[6]-gingerol inhibits colon cancer cell proliferation and induced apoptosis, while the normal colon cells are unaffected. [6]-gingerol down-regulates phorbol myristate acetate induced phosphorylation of ERK1/2 and JNK MAP kinases and activation of AP-1 transcription factor, but has only little effects on phosphorylation of p38 MAP kinase and activation of NF-kappa B. [6]-gingerol treatment is shown to restore impaired intestinal barrier function and to suppress proinflammatory responses in DSS-treated Caco-2 monolayers. AMPK is activated on [6]-gingerol treatment. Treatment with [6]-gingerol results in a significant decrease in the viability of osteosarcoma cells in a dose-dependent fashion. In parallel, the number of cells arrested at the sub-G1 cell cycle phase is significantly increased. [6]-gingerol induces activation of caspase cascades and regulates cellular levels of Bcl2 and Bax.

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究(In Vivo)

In animal studies, [6]-gingerol significantly ameliorates DSS-induced colitis by restoration of body weight loss, reduction in intestinal bleeding, and prevention of colon length shortening. In addition, [6]-gingerol suppresses DSS-elevated production of proinflammatory cytokines (IL-1β, TNFα, and IL-12).

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

运输条件

Room temperature or refrigerated transportation.

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
结构分类
来源
参考文献
溶解度数据
体外研究: 

DMSO : 50 mg/mL (169.84 mM; Need ultrasonic)

配制储备溶液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 3.3969 mL 16.9843 mL 33.9685 mL
5 mM 0.6794 mL 3.3969 mL 6.7937 mL
10 mM 0.3397 mL 1.6984 mL 3.3969 mL
*

产品不同,其溶解度不同。建议根据产品选择合适的溶剂配制储备溶液;配成溶液后,建议分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C 储存时,建议在 6 个月内使用,-20°C 储存时,建议在 1 个月内使用。

体内研究:

建议根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都建议先按照 体外研究 方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    建议依照次序添加每种溶剂: 10% DMSO    40% PEG300    5% Tween-80    45% saline

    Solubility: ≥ 2.5 mg/mL (8.49 mM); Clear solution

    此方案可获得 ≥ 2.5 mg/mL (8.49 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;向上述体系中加入50 μL Tween-80,混合均匀;然后继续加入 450 μL生理盐水定容至 1 mL。

    将 0.9 g 氯化钠,完全溶解于 100 mL ddH?O 中,得到澄清透明的生理盐水溶液
  • 2.

    建议依照次序添加每种溶剂: 10% DMSO    90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.5 mg/mL (8.49 mM); Clear solution

    此方案可获得 ≥ 2.5 mg/mL (8.49 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液中,混合均匀。

    将 2 g 磺丁基醚 β-环糊精加入 5 mL 生理盐水中,再用生理盐水定容至 10 mL,完全溶解,澄清透明
  • 3.

    建议依照次序添加每种溶剂: 10% DMSO    90% corn oil

    Solubility: ≥ 2.5 mg/mL (8.49 mM); Clear solution

    此方案可获得 ≥ 2.5 mg/mL (8.49 mM,饱和度未知) 的澄清溶液,此方案不适用于实验周期在半个月以上的实验。

    以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中,混合均匀。

*
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

相关产品

更多
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2